Inventor
KONG XIANQI
CN40 patents
⚠️ This page may combine multiple inventors who share the name “KONG XIANQI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
RISEN SUZHOU PHARMA TECH CO LTD
18 patentsUS11970490B2Apr 30, 2024
Stable heavy isotopes in amide functional groups and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD4 citations84
US10472323B2Nov 12, 2019
Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD5 citations82
US11225497B2Jan 18, 2022
Prodrugs of a CDK inhibitor for treating cancers
RISEN SUZHOU PHARMA TECH CO LTD2 citations72
US11608314B2Mar 21, 2023
Crystalline form of 3-((L-valyl) amino))-3, 3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD2 citations71
US11186543B2Nov 30, 2021
Crystalline form of 3-((L-valyl)amino))-3,3-dideuterium-1-propanesulfonic acid, preparation method and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD2 citations71
US10954188B2Mar 23, 2021
Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD4 citations71
US10881681B2Jan 5, 2021
CD73 inhibitors and pharmaceutical uses thereof
RISEN SUZHOU PHARMA TECH CO LTD2 citations71
US11725020B2Aug 15, 2023
Prodrugs of a CDK inhibitor for treating cancers
RISEN SUZHOU PHARMA TECH CO LTD0 citations62
US12595260B2Apr 7, 2026
Stable heavy isotopes in amide functional groups and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD0 citations61
US12365675B2Jul 22, 2025
Stable heavy isotopes in amide functional groups and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD0 citations61
US12552823B2Feb 17, 2026
Glucosamine derivatives and pharmaceutical uses thereof
RISEN SUZHOU PHARMA TECH CO LTD0 citations60
US12459888B2Nov 4, 2025
Isotope-enriched 3-amino-1-propanesulfonic acid derivatives and uses thereof
RISEN SUZHOU PHARMA TECH CO LTD0 citations60
US12312378B2May 27, 2025
Glucosamine derivatives for the prevention or treatment of joint disorders
RISEN SUZHOU PHARMA TECH CO LTD0 citations60
US11530234B2Dec 20, 2022
CD73 inhibitors and pharmaceutical uses thereof
RISEN SUZHOU PHARMA TECH CO LTD1 citations60
US12338205B2Jun 24, 2025
Crystalline form of 3-((L-valyl) amino)-1-propanesulfonic acid
RISEN SUZHOU PHARMA TECH CO LTD0 citations59
US11591358B2Feb 28, 2023
Glucosamine derivatives and pharmaceutical uses thereof
RISEN SUZHOU PHARMA TECH CO LTD0 citations59
US12403129B2Sep 2, 2025
Isotope-enriched 3-amino-1-propanesulfonic acid derivatives for the treatment of cerebrovascular disease
RISEN SUZHOU PHARMA TECH CO LTD0 citations51
US11718636B2Aug 8, 2023
Glucosamine derivatives for the prevention or treatment of joint disorders
RISEN SUZHOU PHARMA TECH CO LTD0 citations50
NEUROCHEM INT LTD
6 patentsUS7253306B2Aug 7, 2007
Pharmaceutical drug candidates and methods for preparation thereof
NEUROCHEM INT LTD33 citations92
US7244764B2Jul 17, 2007
Methods and compositions for treating amyloid-related diseases
NEUROCHEM INT LTD29 citations92
US7414076B2Aug 19, 2008
Methods and compositions for treating amyloid-related diseases
NEUROCHEM INT LTD24 citations91
US7393875B2Jul 1, 2008
Methods and compounds for inhibiting amyloid deposits
NEUROCHEM INT LTD9 citations83
US7262223B2Aug 28, 2007
Amidine derivatives for treating amyloidosis
NEUROCHEM INT LTD18 citations83
US7311893B2Dec 25, 2007
Amyloid targeting imaging agents and uses thereof
NEUROCHEM INT LTD11 citations81
KONG XIANQI
5 patentsUS8748656B2Jun 10, 2014
Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
KONG XIANQI17 citations90
US8835654B2Sep 16, 2014
Method and compositions for treating amyloid-related diseases
KONG XIANQI9 citations82
US8642801B2Feb 4, 2014
Methods and compositions for treating amyloid-related diseases
KONG XIANQI11 citations82
US9051248B2Jun 9, 2015
Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
KONG XIANQI1 citations51
US9233913B2Jan 12, 2016
Amino acid derivatives for the treatment of neuropathic pain
KONG XIANQI0 citations35
BELLUS HEALTH INC
3 patentsUS8044100B2Oct 25, 2011
Methods and compositions for treating amyloid-related diseases
BELLUS HEALTH INC9 citations81
US11020360B2Jun 1, 2021
Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
BELLUS HEALTH INC1 citations71
US10857109B2Dec 8, 2020
Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
BELLUS HEALTH INC3 citations71